Skip to main content
OpenTrials

Clinical trial condition

Salivary Gland Diseases

Explore clinical trials studying Salivary Gland Diseases. Study availability and eligibility vary by location and protocol.

710 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Salivary Gland Diseases trial results

Active, Not Recruiting

Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers

NCT04209660

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +12 more
Locations
  • Baptist Alliance MCI Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

NCT05608876

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations
  • The Kinghorn Cancer Centre Sydney, New South Wales, Australia
  • Metro South Hospital and Health Service, via the Princess Alexandra Hospital Brisbane, Queensland, Australia
  • Cardiff and Vale University Health Board - University Hospital of Wales (UHW) Cardiff, United Kingdom
  • East and North Hertfordshire NHS Trust (Incorporating Mount Vernon Cancer Centre) of Lister Hospital Stevenage, Hertfordshire, United Kingdom
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

NCT04576091

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details

Related conditions